StreetInsider.com Morning Movers:

Akorn, Inc. (NASDAQ: AKRX) 44% HIGHER; Akorn-Strides, LLC announced that the FDA has granted approvals for two Abbreviated New Drug Applications for Sterile Vancomycin HCl USP, 500 mg/vial, 1 g/vial and Sterile Vancomycin HCl USP, 5 g/vial Pharmacy Bulk Package. Akorn-Strides, LLC is a Joint Venture that was formed in 2004 by Akorn, Inc. (NASDAQ: AKRX) and Strides Arcolab Limited.

Labopharm Inc. (Nasdaq: DDSS) 43% HIGHER; announced that RYZOLT, its once-daily formulation of the analgesic tramadol, has been approved by the FDA. RYZOLT is indicated for the management of moderate to moderately severe chronic pain in